DTxPharma
Biotechnology ResearchCalifornia, United States11-50 Employees
DTx Pharma was acquired by Novartis in July of 2023. This page is no longer active. Thank you to our followers and please follow Novartis for future updates.
DTxPharma uses 8 technology products and services including Oracle Data Guard, Apache Spark, GitHub, and more. Explore DTxPharma's tech stack below.
| DTxPharma Email Formats | Percentage |
| FLast@dtxpharma.com | 98% |
| First@dtxpharma.com | 2% |
| First.Last@novartis.com | 89% |
| F.Last@novartis.com | 5% |
| FiLast@novartis.com | 3% |
| FLast@novartis.com | 3% |
Biotechnology ResearchCalifornia, United States11-50 Employees
DTx Pharma was acquired by Novartis in July of 2023. This page is no longer active. Thank you to our followers and please follow Novartis for future updates.
DTxPharma has raised a total of $100M of funding over 5 rounds. Their latest funding round was raised on Mar 01, 2021 in the amount of $100M.
DTxPharma's revenue is estimated to be in the range of $1M$10M
DTxPharma has raised a total of $100M of funding over 5 rounds. Their latest funding round was raised on Mar 01, 2021 in the amount of $100M.
DTxPharma's revenue is estimated to be in the range of $1M$10M